Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-EN | Version v8-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-04-01 | 2025-04-01 |
| Drug Identification Number | 02295695 | 02295695 |
| Brand name | SUBOXONE | SUBOXONE |
| Common or Proper name | SUBOXONE TAB 2MG/0.5MG 28s | SUBOXONE TAB 2MG/0.5MG 28s |
| Company Name | INDIVIOR UK LIMITED | INDIVIOR UK LIMITED |
| Ingredients | NALOXONE BUPRENORPHINE | NALOXONE BUPRENORPHINE |
| Strength(s) | 0.5MG 2MG | 0.5MG 2MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | SUBLINGUAL SUBLINGUAL | SUBLINGUAL SUBLINGUAL |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 28 | 28 |
| ATC code | N07BC | N07BC |
| ATC description | DRUGS USED IN ADDICTIVE DISORDERS | DRUGS USED IN ADDICTIVE DISORDERS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2025-03-18 | 2025-03-18 |
| Actual start date | 2025-03-18 | 2025-03-18 |
| Estimated end date | 2025-04-02 | 2025-04-02 |
| Actual end date | 2025-03-31 | 2025-03-31 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Delay in product release | Delay in product release |
| Health Canada comments |